MindMed to Participate in March Investor Conferences

Rhea-AI Summary

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has announced its participation in three upcoming investor conferences. The events include the Cowen 43rd Annual Healthcare Conference on March 8, 2023, at 1:30 pm EST, the Oppenheimer 33rd Annual Healthcare Conference on March 13, 2023, at 2:00 pm EST, and the 35th Annual Roth Conference on March 13, 2023, at 2:30 pm PST/5:30 pm EST. Webcasts for each conference will be available on MindMed's Investor Resources page for up to 90 days post-event. MindMed is focused on developing innovative treatments targeting brain health disorders, showcasing its commitment to improving patient outcomes.

NEW YORK--(BUSINESS WIRE)-- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company's management team will participate in the following investor conferences:

• Cowen 43rd Annual Healthcare Conference
  • Format: Investor Presentation
  • Date and Time: Wednesday, March 8, 2023 at 1:30 pm EST
  • Webcast Link: Cowen Healthcare Conference
• Oppenheimer 33rd Annual Healthcare Conference
  • Format: Investor Presentation
  • Date and Time: Monday, March 13, 2023 at 2:00 pm EST
  • Webcast Link: Oppenheimer 33rd Annual Healthcare Conference
• 35th Annual Roth Conference
  • Format: Fireside Chat
  • Date and Time: Monday, March 13, 2023 at 2:30 pm PST/5:30 pm EST
  • Webcast Link: ​​35th Annual Roth Conference

Audio webcasts and replays of these presentations will be available on MindMed’s Investor Resources website for up to 90 days following each event.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230228005602/en/

For Media & Investor Inquiries, please contact:

Maxim Jacobs, CFA

Vice President, Investor Relations and Corporate Communications

Mind Medicine (MindMed) Inc.

ir@mindmed.co

media@mindmed.co

Source: MindMed

FAQ

What conferences is Mind Medicine (MNMD) participating in March 2023?

Mind Medicine will participate in the Cowen 43rd Annual Healthcare Conference on March 8, the Oppenheimer 33rd Annual Healthcare Conference on March 13, and the 35th Annual Roth Conference on March 13.

When is the Cowen 43rd Annual Healthcare Conference for MNMD?

The Cowen 43rd Annual Healthcare Conference will take place on March 8, 2023, at 1:30 pm EST.

What is the date and time of the Oppenheimer 33rd Annual Healthcare Conference for MNMD?

The Oppenheimer 33rd Annual Healthcare Conference is scheduled for March 13, 2023, at 2:00 pm EST.

When will the 35th Annual Roth Conference for MNMD occur?

The 35th Annual Roth Conference will occur on March 13, 2023, at 2:30 pm PST/5:30 pm EST.

Where can I find the webcasts for Mind Medicine's investor presentations?

Webcasts for Mind Medicine's investor presentations will be available on their Investor Resources page for up to 90 days after each event.